NT-pro-BNP levels and their response to exercise in patients with slow coronary flow

Arquivos Brasileiros de Cardiologia

Volumn 99, Issue 6, 2012, Pages 1115-1122

  Yurtdaş, Mustafa ^a   Özcan, Ismail Türkay ^b   Çamsari, Ahmet ^b   Çiçek, Dilek ^b   Tamer, Lülüfer ^b   Cin, Veli Gökhan ^b   Döven, Oben ^b   Seyis, Ali Sabri ^c   Akkuş, Mehmet Necdet ^b  

^a Medisina Hospital   (Turkey)

^b MERSIN UNIVERSITY   (Turkey)

^c MEDICAL PARK HOSPITAL   (Turkey)

Author keywords

Angina pectoris; Coronary circulation; Exercise; Natriuretic agents

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; ANGINA PECTORIS; ARTICLE; BLOOD CLOT LYSIS; BLOOD FLOW VELOCITY; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; EXERCISE; FEMALE; HEART INFARCTION; HUMAN; IMMUNOASSAY; ISCHEMIA; MALE; ST SEGMENT DEPRESSION; TREADMILL EXERCISE;

ANGINA PECTORIS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CASE-CONTROL STUDIES; CORONARY CIRCULATION; EXERCISE; EXERCISE TEST; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; STATISTICS, NONPARAMETRIC;

EID: 84872937443     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Kemp HG, Kronmal RA, Vlietstra RE, Frye RL. Seven year survival of patients with normal or near normal coronary arteriograms: a CASS registry study. J Am Coll Cardiol. 1986;7(3):479-483.
2. Kemp HG Jr. Left ventricular function in patients with the anginal syndrome and normal coronary arteriograms. Am J Cardiol. 1973;32(3):375-376.
3. Voelker W, Euchaner U, Dittmann H, Karsch KR. Long-term clinical course of patients with angina and angiographically normal coronary arteries. Clin Cardiol. 1991;14(4):4307-4311.
4. Tambe AA, Demany MA, Zimmerman HA, Mascarenhas E. Angina pectoris and slow flow velocity of dye in coronary arteries: a new angiographic finding. Am Heart J. 1972;84(1):66-71.
5. Gunes Y, Gumrukcuoglu HA, Akdag S, Simsek H, Sahin M, Tuncer M. Vascular endothelial function in patients with slow coronary flow and the effects of Nebivolol. Arq Bras Cardiol. 2011;97(4):275-280.
6. Mosseri M, Yarom R, Gotsman MS, Hasin Y. Histologic evidence for small vessel coronary artery disease in patients with angina pectoris and patent large coronary arteries. Circulation. 1986;74(5):964-972.
7. Mangieri E, Macchiarelli G, Ciavolella M, Barilla F, Avella A, Martinotti A, et al. Slow coronary flow: clinical and histopathological features in patients with otherwise normal epicardial coronary arteries. Cathet Cardiovasc Diagn. 1996;37(4):375-381.
8. Munagala VK, Burnett JC, Redfield MM. The natriuretic peptides in cardiovascular medicine. Curr Probl Cardiol. 2004;29(12):707-769.
9. Yeo KT, Lee HK, Wong KC, Foote RS. Can exercise-induced changes in B-type natriuretic peptides be used to detect cardiac ischemia? J Card Fail. 2005;11(5 Suppl):S59-S64.
10. Kuwahara K, Saito Y, Ogawa Y, Tamura N, Ishikawa M, Harada M, et al. Interaction of myocytes and nonmyocytes is necessary for mechanical stretch to induce ANP/BNP production in cardiocyte culture. J Cardiovasc Pharmacol. 1998;31(Suppl 1):S357-S359.
11. Bruneau BG, Piazza LA, De Bold AJ. BNP gene expression is specifically modulated by stretch and ET-1 in a new model of isolated rat atria. Am J Physiol Heart Circ Physiol. 1997;273(6 Pt 2):H2678-H2686.
12. Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation. 1994;90(1):195-203.
13. Ikeda T, Matsuda K, Itoh H, Shirakami G, Miyamoto Y, Yoshimasa T, et al. Plasma levels of brain and atrial natriuretic peptides elevate in proportion to left ventricular end systolic wall stress in patients with aortic stenosis. Am Heart J. 1997;133(3):307-314.
14. Magga J, Marttila M, Mantymaa P, Vuolteenaho O, Ruskoaho H. Brain natriuretic peptide in plasma, atria, and ventricles of vasopressin and phenylephrine-infused conscious rats. Endocrinology. 1994;134(6):2505-2515.
15. Foote RS, Pearlman JD, Siegel AH, Yeo KT. Detection of Exercise-Induced Ischemia by Changes in B-type natriuretic peptides. J Am Coll Cardiol. 2004;44(10):1980-1987.
16. Ndrepepa G, Braun S, Mehilli J, von Beckerath N, Vogt W, Schomig A, et al. Plasma levels of n-terminal pro-brain natriuretic peptide in patients with coronary artery disease and relation to clinical presentation, angiographic severity, and left ventricular ejection fraction. Am J Cardiol. 2005;95(5):553-557.
17. Sabatine MS, Morrow DA, de Lemos JA, Omland T, Desai MY, Tansyevic N, et al. Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia. J Am Coll Cardiol. 2004;44(10):1988-1995.
18. Gibson CM, Cannon CP, Daley WL, Dodge JT Jr, Alexandr B Jr, Marble SJ, et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation. 1996;93(5):879-888.
19. Fletcher GF, Balady G, Froelicher VF, Hartley LH, Haskell WL, Pollock ML. Exercise standards: a statement for health care professionals from the American Heart Association Writing Group. Circulation. 1995;91(2):580-615.
20. Shue P, Froelicher V. Extra: an expert system for exercise reporting. J Noninvasive Test. 1998;II-4:21-27.
21. Van Lierde J, Vrolix M, Sionis D, De Geest H, Piessens J. Lack of evidence for small vessel disease in a patient with 'slow dye progression' in the coronary arteries. Cathet Cardiovasc Diagn. 1991;23(2):117-120.
22. Pekdemir H, Polat G, Cin VG, Camsari A, Cicek D, Akkus MN, et al. Elevated plasma endothelin-1 levels in coronary sinus during rapid right atrial pacing in patients with slow coronary flow. Int J Cardiol. 2004;97(1):35-41.
23. Cin VG, Pekdemir H, Camsari A, Cicek D, Akkus MN, Parmaksyz T, et al. Diffuse intimal thickening of coronary arteries in slow coronary flow. Jpn Heart J. 2003;44(6):907-919.
24. Hopkins WE, Chen Z, Fukagawa NK, Hall C, Knot HJ, LeWinter MM. Increased atrial and brain natriuretic peptides in adults with cyanotic congenital heart disease: enhanced understanding of the relationship between hypoxia and natriuretic peptide secretion. Circulation. 2004;109(23):2872-2877.
25. Beltrame JF, Limaye SB, Wuttke RD, Horowitz JD. Coronary hemodynamic and metabolic studies of the coronary slow flow phenomenon. Am Heart J. 2003;146(1):84-90.
26. Madak N, Nazli Y, Mergen H, Aysel S, Kandaz M, Yanik E, et al. Acute phase reactants in patients with coronary slow flow phenomenon. Anadolu Kardiyol Derg. 2010;10(5):416-420.
27. Cordero DL, Cagin NA, Natelson BH. Neurocardiology update: Role of the nervous system in coronary vasomotion. Cardiovasc Res. 1995;29(3):319-328.
28. Feigl EO. Adrenergic control of transmural coronary blood flow. Basic Res Cardiol. 1990;85 Suppl I:167-176.
29. Zehier AM, Drexler H, Wollschlaeger H, Saurbier B, Just H. Coronary vasomotion in response to sympathetic stimulation in humans: Importance of the functional integrity of the endothelium. J Am Coll Cardiol. 1989;14(5):1181-1190.
30. Kaski JC, Cox ID, Crook JR, Salomone OA, Fredericks S, Hann C, et al. Differential plasma endothelin concentrations in subgroups of patients with angina and angiographically normal coronary arteries: Coronary Artery Disease Research Group. Am Heart J. 1998;136(3):412-417.
31. Camsari A, Pekdemir H, Cicek D, Polat G, Akkus MN, Doven O, et al. Endothelin-1 and nitric oxide concentrations and their response to exercise in patients with slow coronary flow. Circ J. 2003;67(12):1022-1028.